Microalgae as potential sources of bioactive compounds for functional foods and pharmaceuticals

Detalhes bibliográficos
Autor(a) principal: Silva, Mélanie
Data de Publicação: 2022
Outros Autores: Kamberovic, Farah, Uota, Sisay Tesema, Kovan, Ismael-Mohammed, Viegas, Carla, Simes, D, Gangadhar, Katkam N., João, Varela, Barreira, Luísa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.1/17990
Resumo: Microalgae are an untapped source of bioactive compounds with various biotechnological applications. Several species are industrially produced and commercialized for the feed or cosmetic industries, however, other applications in the functional food and pharmaceutical markets can be foreseen. In this study, nine industrial/commercial species were evaluated for in vitro antioxidant, calcium-chelating, anti-tumoral, and anti-inflammatory activities. The most promising extracts were fractionated yielding several promising fractions namely, of Tetraselmis striata CTP4 with anti-inflammatory activity (99.0 ± 0.8% reduction in TNF-α production in LPS stimulated human macrophages at 50 µg/mL), of Phaeodactylum Tricornutum with cytotoxicity towards cancerous cell lines (IC50 = 22.3 ± 1.8 µg/mL and 27.5 ± 1.6 µg/mL for THP-1 and HepG2, respectively) and of Porphyridium sp. and Skeletonema sp. with good chelating activity for iron, copper and calcium (IC50 = 0.047, 0.272, 0.0663 mg/mL and IC50 = 0.055, 0.240, 0.0850 mg/mL, respectively). These fractions were chemically characterized by GC–MS after derivatization and in all, fatty acids at various degrees of unsaturation were the most abundant compounds. Some of the species under study proved to be potentially valuable sources of antioxidant, metal chelators, anti-tumoral and anti-inflammatory compounds with possible application in the functional food and pharmaceutical industries.
id RCAP_7ed7e063935bf7e12af193058db311ce
oai_identifier_str oai:sapientia.ualg.pt:10400.1/17990
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Microalgae as potential sources of bioactive compounds for functional foods and pharmaceuticalsAnti-inflammatory activityAnti-tumoral activityAntioxidant activityBioactive compoundsNeuroprotective compoundsHealth benefitsMicroalgae are an untapped source of bioactive compounds with various biotechnological applications. Several species are industrially produced and commercialized for the feed or cosmetic industries, however, other applications in the functional food and pharmaceutical markets can be foreseen. In this study, nine industrial/commercial species were evaluated for in vitro antioxidant, calcium-chelating, anti-tumoral, and anti-inflammatory activities. The most promising extracts were fractionated yielding several promising fractions namely, of Tetraselmis striata CTP4 with anti-inflammatory activity (99.0 ± 0.8% reduction in TNF-α production in LPS stimulated human macrophages at 50 µg/mL), of Phaeodactylum Tricornutum with cytotoxicity towards cancerous cell lines (IC50 = 22.3 ± 1.8 µg/mL and 27.5 ± 1.6 µg/mL for THP-1 and HepG2, respectively) and of Porphyridium sp. and Skeletonema sp. with good chelating activity for iron, copper and calcium (IC50 = 0.047, 0.272, 0.0663 mg/mL and IC50 = 0.055, 0.240, 0.0850 mg/mL, respectively). These fractions were chemically characterized by GC–MS after derivatization and in all, fatty acids at various degrees of unsaturation were the most abundant compounds. Some of the species under study proved to be potentially valuable sources of antioxidant, metal chelators, anti-tumoral and anti-inflammatory compounds with possible application in the functional food and pharmaceutical industries.EC/H2020/101000501/EU; AAC No. 41/ALG/2020—Project No. 072583MDPISapientiaSilva, MélanieKamberovic, FarahUota, Sisay TesemaKovan, Ismael-MohammedViegas, CarlaSimes, DGangadhar, Katkam N.João, VarelaBarreira, Luísa2022-07-14T09:44:21Z2022-06-092022-06-23T12:11:47Z2022-06-09T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.1/17990engApplied Sciences 12 (12): 5877 (2022)10.3390/app121258772076-3417info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-06T02:03:02Zoai:sapientia.ualg.pt:10400.1/17990Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:07:45.083108Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Microalgae as potential sources of bioactive compounds for functional foods and pharmaceuticals
title Microalgae as potential sources of bioactive compounds for functional foods and pharmaceuticals
spellingShingle Microalgae as potential sources of bioactive compounds for functional foods and pharmaceuticals
Silva, Mélanie
Anti-inflammatory activity
Anti-tumoral activity
Antioxidant activity
Bioactive compounds
Neuroprotective compounds
Health benefits
title_short Microalgae as potential sources of bioactive compounds for functional foods and pharmaceuticals
title_full Microalgae as potential sources of bioactive compounds for functional foods and pharmaceuticals
title_fullStr Microalgae as potential sources of bioactive compounds for functional foods and pharmaceuticals
title_full_unstemmed Microalgae as potential sources of bioactive compounds for functional foods and pharmaceuticals
title_sort Microalgae as potential sources of bioactive compounds for functional foods and pharmaceuticals
author Silva, Mélanie
author_facet Silva, Mélanie
Kamberovic, Farah
Uota, Sisay Tesema
Kovan, Ismael-Mohammed
Viegas, Carla
Simes, D
Gangadhar, Katkam N.
João, Varela
Barreira, Luísa
author_role author
author2 Kamberovic, Farah
Uota, Sisay Tesema
Kovan, Ismael-Mohammed
Viegas, Carla
Simes, D
Gangadhar, Katkam N.
João, Varela
Barreira, Luísa
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Sapientia
dc.contributor.author.fl_str_mv Silva, Mélanie
Kamberovic, Farah
Uota, Sisay Tesema
Kovan, Ismael-Mohammed
Viegas, Carla
Simes, D
Gangadhar, Katkam N.
João, Varela
Barreira, Luísa
dc.subject.por.fl_str_mv Anti-inflammatory activity
Anti-tumoral activity
Antioxidant activity
Bioactive compounds
Neuroprotective compounds
Health benefits
topic Anti-inflammatory activity
Anti-tumoral activity
Antioxidant activity
Bioactive compounds
Neuroprotective compounds
Health benefits
description Microalgae are an untapped source of bioactive compounds with various biotechnological applications. Several species are industrially produced and commercialized for the feed or cosmetic industries, however, other applications in the functional food and pharmaceutical markets can be foreseen. In this study, nine industrial/commercial species were evaluated for in vitro antioxidant, calcium-chelating, anti-tumoral, and anti-inflammatory activities. The most promising extracts were fractionated yielding several promising fractions namely, of Tetraselmis striata CTP4 with anti-inflammatory activity (99.0 ± 0.8% reduction in TNF-α production in LPS stimulated human macrophages at 50 µg/mL), of Phaeodactylum Tricornutum with cytotoxicity towards cancerous cell lines (IC50 = 22.3 ± 1.8 µg/mL and 27.5 ± 1.6 µg/mL for THP-1 and HepG2, respectively) and of Porphyridium sp. and Skeletonema sp. with good chelating activity for iron, copper and calcium (IC50 = 0.047, 0.272, 0.0663 mg/mL and IC50 = 0.055, 0.240, 0.0850 mg/mL, respectively). These fractions were chemically characterized by GC–MS after derivatization and in all, fatty acids at various degrees of unsaturation were the most abundant compounds. Some of the species under study proved to be potentially valuable sources of antioxidant, metal chelators, anti-tumoral and anti-inflammatory compounds with possible application in the functional food and pharmaceutical industries.
publishDate 2022
dc.date.none.fl_str_mv 2022-07-14T09:44:21Z
2022-06-09
2022-06-23T12:11:47Z
2022-06-09T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.1/17990
url http://hdl.handle.net/10400.1/17990
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Applied Sciences 12 (12): 5877 (2022)
10.3390/app12125877
2076-3417
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133322752819200